All clinical trials on the European Union Clinical Trials Register (EUCTR) must report their results in the registry within a year of completion. This site tracks who's doing this and who isn't. Learn more »
These trials completed more than 12 months ago and should have reported results. Some have, some have not.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
|Status||Trial ID||Title||Completion date||Category|
|Completed, but no date Terminated||2012-001948-21||Open Phase II Study of Ketoconazole as Inhibitor of the Enzyme CYP17 in Locally Advanced or Disseminated Granulosa Cell Tumour of Ovary. GreKo Study. Estudio fase II abierto de ketoconazol como inh...||bad-data|
|Completed, but no date Terminated||2013-003128-35||Open label phase II clinical trial of Orteronel (TAK-700) in metastatic or advanced non-resectable granulosa cell ovarian tumors. The Greko II study. Ensayo clínico fase II abierto de Orteronel (TA...||bad-data|
|Not reported Terminated||2015-004469-10||Open label phase II clinical trial of enzalutamide in metastatic or advanced non-resectable granulosa cell ovarian tumors. GreKo III study. Ensayo clínico fase II abierto de enzalutamida en cáncer ...||2020-11-24||due-trials|
|Not reported Terminated||2016-003946-99||A multicenter phase 2 study of nivolumab combined with ipilimumab in patients with pediatric solid tumors presenting in adulthood Estudio multicéntrico, fase 2 de nivolumab en combinación con ipili...||2021-07-27||due-trials|